PRESS RELEASE: IVI Elects New Board Members
New Directors Reflect Diverse Sectors of Healthcare Alexandria, VA — January 18, 2022 — The Innovation and Value Initiative (IVI), an independent, nonprofit research organization dedicated to advancing patient-centric value assessment, has elected eight [...]
Frequently Asked Questions about the IVI Draft Protocol for Major Depressive Disorder
The Innovation and Value Initiative welcomes public comments on its draft model protocol on major depressive disorder. The deadline to submit comments has been extended to Tuesday, January 25th. This economic model currently under [...]
Ms. Stacey Courtnay Explores Key Findings from IVI and Arthritis Foundation Research
In a commentary published by the American Journal of Managed Care on December 17, 2021, Ms. Stacy Courtnay highlights how lived experiences like hers can inform healthcare research. In "In Evaluating Rheumatoid Arthritis Treatments, Involving [...]
Value In Medicaid, Part 2: Challenges Concerning Health-Related Social Needs
In the second of a two-part Health Affairs post, Dr. Anish Mahajan writes about several challenges concerning health-related social needs in the journey to value in Medicaid. He addresses challenges including use of social needs screening tools, case [...]
PRESS RELEASE: IVI Opens Public Comment Period for Major Depressive Disorder Model Draft Protocol
Nonprofit Seeks Input into Data Sources and Technical Specifications to Guide Model Development Will Hold December 15th Webinar to Overview Protocol and Public Comment Process Alexandria, VA — December 14, 2021 — The Innovation [...]
Jennifer Bright Shares Views on a Patient-Centered Learning Health System
In a Journal of Accountable Care commentary, IVI Executive Director Jennifer Bright writes that to move toward a truly patient-centered learning health system, data transparency and common-good use must be a greater priority. She describes [...]
Value In Medicaid, Part 1: Administrative, Regulatory, And Financial Challenges
Part 1 in a two-part blog series by Anish P. Mahajan, MD, the Chief Executive Officer of Harbor-UCLA Medical Center and Associate Dean at UCLA-Geffen School of Medicine, examines the administrative, regulatory, and financial challenges [...]
Harmonization Of Health Technology Assessment Across The European Union: Lessons For The United States
In the latest piece of the IVI and Health Affairs blog series, Rosanna Tarricone and James Robinson compare the U.S. HTA landscape with experiences in Europe, using it to draw some lessons learned. The authors [...]
PRESS RELEASE: IVI Presents Research Poster and Participates in Two Panels at ISPOR Europe 2021
Innovation and Value Initiative Research Identifies Concrete Steps to Increase Patient Representativeness in Healthcare Research Alexandria, VA — November 30, 2021 — The Innovation and Value Initiative (IVI), an independent, nonprofit research organization dedicated to [...]
Pursuing Health Care Value Post-COVID-19: Keep The Focus On Patients
At the midpoint of the Health Affairs and IVI blog series, PCORI's Nakela Cook discusses an essential lesson from the pandemic that must be applied to clinical research, healthcare delivery, and public health – patients [...]
How Current Cost-Effectiveness Analyses Distort Drug Development Priorities
In the latest post in our ongoing series with Health Affairs blog, Soeren Mattke takes on the relationship value assessment and innovation of new therapies. He argues that cost-effectiveness analysis, one of the most common [...]
IVI MEMBER SPOTLIGHT: Danny van Leeuwen
This year we are pleased to welcome Danny van Leeuwen as a new member of the Innovation and Value Initiative. Danny is the host of HealthHats, a podcast and blog that helps people [...]